The reported statements, read against the company's own industry.
Financials view
Market Capitalization
4.71BCNY
704.93M · vs all stocks (USD)
Updated Oct 22, 2026
Revenue (TTM)
2.25BCNY
337.70M · vs all stocks (USD)
Updated Oct 22, 2026
Profit Margin
-37.23%
vs Conglomerates peers
Updated Oct 22, 2026
Beta
0.4640x
vs all stocks
Updated Oct 22, 2026
52-Week Change
-19.25%
vs all stocks
Updated Oct 22, 2026
Market Capitalization
4.71BCNY
704.93M · vs all stocks (USD)
Updated Oct 22, 2026
Enterprise Value
7.31BCNY
1.09B · vs all stocks (USD)
Updated Oct 22, 2026
Forward P/E
13.76x
vs Conglomerates peers
Updated Oct 22, 2026
Price to Sales (TTM)
2.19x
vs Conglomerates peers
Provider-reported. Market Capitalization ÷ Revenue (TTM) on this page gives 2.09×.Updated Oct 22, 2026
Price to Book (MRQ)
2.91x
vs Conglomerates peers
Updated Oct 22, 2026
Enterprise to Revenue
3.24x
vs Conglomerates peers
Updated Oct 22, 2026
Enterprise to EBITDA
-16.63x
vs Conglomerates peers
Updated Oct 22, 2026
Gross Margin
-11.21%
vs Conglomerates peers
Provider-reported. Gross Profit (TTM) ÷ Revenue (TTM) on this page gives -14.78%.Updated Oct 22, 2026
Profit Margin
-37.23%
vs Conglomerates peers
Updated Oct 22, 2026
Operating Margin
-44.89%
vs Conglomerates peers
Updated Oct 22, 2026
Return on Assets (TTM)
-6.09%
vs Conglomerates peers
Updated Oct 22, 2026
Return on Equity (TTM)
-43.26%
vs Conglomerates peers
Updated Oct 22, 2026
Revenue (TTM)
2.25BCNY
337.70M · vs all stocks (USD)
Updated Oct 22, 2026
Revenue per Share (TTM)
2.07CNYUpdated Oct 22, 2026
Quarterly Revenue Growth
-31.60%
vs Conglomerates peers
Updated Oct 22, 2026
Gross Profit (TTM)
-333.27MCNY
-49.92M · vs all stocks (USD)
Updated Oct 22, 2026
EBITDA (TTM)
-439.42MCNY
-65.83M · vs all stocks (USD)
Updated Oct 22, 2026
Net Income (TTM)
-839.40MCNY
-125.74M · vs all stocks (USD)
Updated Oct 22, 2026
Quarterly Earnings Growth (YoY)
-34.20%
vs Conglomerates peers
Updated Oct 22, 2026
Operating Cash Flow (TTM)
-316.23MCNY
-47.37M · vs all stocks (USD)
Updated Oct 22, 2026
Levered Free Cash Flow (TTM)
-246.74MCNY
-36.96M · vs all stocks (USD)
Updated Oct 22, 2026
5-Year Average Dividend Yield
2.84%
vs all stocks
Updated Oct 22, 2026
Payout Ratio
0.00%
vs Conglomerates peers
Updated Oct 22, 2026
Minority Interest (Equity)
65.98MCNYFY2025 · Dec 31, 2025
Revenue
2.92BCNYFY2025 · Dec 31, 2025
Cost of Goods Sold
3.05BCNYFY2025 · Dec 31, 2025
Gross Profit
-132.96MCNYFY2025 · Dec 31, 2025
Operating Income
-406.57MCNY
-60.90M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Pre-tax Income
-727.57MCNYFY2025 · Dec 31, 2025
Income Tax Expense
65.67MCNYFY2025 · Dec 31, 2025
Net Income
-793.24MCNYFY2025 · Dec 31, 2025
EBIT
-649.54MCNYFY2025 · Dec 31, 2025
EBITDA (Income Statement)
-113.88MCNYFY2025 · Dec 31, 2025
Research & Development
92.50MCNYFY2025 · Dec 31, 2025
Selling, General & Administrative
55.18MCNYFY2025 · Dec 31, 2025
Other Operating Expenses
34.50MCNYFY2025 · Dec 31, 2025
Non-operating Interest Income
8.31MCNYFY2025 · Dec 31, 2025
Non-operating Interest Expense
78.03MCNYFY2025 · Dec 31, 2025
EPS (Basic)
-0.6675CNYFY2025 · Dec 31, 2025
EPS (Diluted)
-0.6675CNYFY2025 · Dec 31, 2025
Basic Shares Outstanding
1.09BSharesFY2025 · Dec 31, 2025
Diluted Shares Outstanding
1.09BSharesFY2025 · Dec 31, 2025
Net Income from Continuing Operations
-793.24MCNYFY2025 · Dec 31, 2025
Minority Interests (P&L)
66.07MCNYFY2025 · Dec 31, 2025
Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025
Operating Cash Flow
-775.29MCNYFY2025 · Dec 31, 2025
Free Cash Flow
-878.40MCNYFY2025 · Dec 31, 2025
Cash & Cash Equivalents (End of Period)
496.66MCNYFY2025 · Dec 31, 2025
Starting Profit (CF Statement)
-793.24MCNYFY2025 · Dec 31, 2025
Other Non-cash Items
85.49MCNYFY2025 · Dec 31, 2025
Change in Accounts Receivable (CF)
-114.02MCNYFY2025 · Dec 31, 2025
Change in Other Assets/Liabilities
46.49MCNYFY2025 · Dec 31, 2025
Capital Expenditures
-103.11MCNYFY2025 · Dec 31, 2025
Purchase of Investments
-1.78MCNYFY2025 · Dec 31, 2025
Sale of Investments
2.03MCNYFY2025 · Dec 31, 2025
Net Investing Cash Flow
-102.86MCNYFY2025 · Dec 31, 2025
Long-term Debt Issuance
1.45BCNYFY2025 · Dec 31, 2025
Long-term Debt Payments
-1.03BCNYFY2025 · Dec 31, 2025
Common Dividends Paid
-69.65MCNYFY2025 · Dec 31, 2025
Other Financing Charges
255.71MCNYFY2025 · Dec 31, 2025
Net Financing Cash Flow
603.19MCNYFY2025 · Dec 31, 2025
Shares Outstanding
1.09BSharesUpdated Oct 22, 2026
Float Shares
437.42MSharesUpdated Oct 22, 2026
% Held by Insiders
60.68%
vs all stocks
Updated Oct 22, 2026
% Held by Institutions
0.28%
vs all stocks
Updated Oct 22, 2026
Total Cash (MRQ)
431.02MCNY
64.57M · vs all stocks (USD)
Updated Oct 22, 2026
Total Cash per Share (MRQ)
0.3960CNYUpdated Oct 22, 2026
Total Debt (MRQ)
2.79BCNY
417.55M · vs all stocks (USD)
Updated Oct 22, 2026
Total Debt to Equity (MRQ)
1.64x
vs Conglomerates peers
Updated Oct 22, 2026
Current Ratio (MRQ)
0.7820x
vs Conglomerates peers
Updated Oct 22, 2026
Book Value per Share (MRQ)
1.56CNYUpdated Oct 22, 2026
Total Assets
6.23BCNY
933.57M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Total Current Assets
2.50BCNYFY2025 · Dec 31, 2025
Total Liabilities
4.14BCNYFY2025 · Dec 31, 2025
Total Non-current Assets
3.74BCNYFY2025 · Dec 31, 2025
Total Non-current Liabilities
1.54BCNYFY2025 · Dec 31, 2025
Total Current Liabilities
2.60BCNYFY2025 · Dec 31, 2025
Cash
496.78MCNYFY2025 · Dec 31, 2025
Cash Equivalents
132.26MCNYFY2025 · Dec 31, 2025
Cash & Cash Equivalents
629.04MCNYFY2025 · Dec 31, 2025
Accounts Receivable
859.92MCNYFY2025 · Dec 31, 2025
Inventory
398.13MCNYFY2025 · Dec 31, 2025
Accounts Payable
640.78MCNYFY2025 · Dec 31, 2025
Short-term Debt
1.48BCNYFY2025 · Dec 31, 2025
Other Current Liabilities
349.95MCNYFY2025 · Dec 31, 2025
Long-term Debt
1.38BCNYFY2025 · Dec 31, 2025
Common Stock (Book)
1.09BCNYFY2025 · Dec 31, 2025
Retained Earnings
-3.25BCNYFY2025 · Dec 31, 2025
Total Shareholders' Equity
2.09BCNY
313.30M · vs all stocks (USD)
FY2025 · Dec 31, 2025
52-Week Low
3.56CNYUpdated Oct 22, 2026
52-Week High
8.26CNYUpdated Oct 22, 2026
52-Week Change
-19.25%
vs all stocks
Updated Oct 22, 2026
Beta
0.4640x
vs all stocks
Updated Oct 22, 2026
50-Day MA
4.82CNYUpdated Oct 22, 2026
200-Day MA
5.37CNYUpdated Oct 22, 2026
Avg 10-Day Volume
59.39MSharesUpdated Oct 22, 2026
Avg 30-Day Volume
46.55MSharesUpdated Oct 22, 2026
Diluted EPS (TTM)
-0.7700CNYUpdated Oct 22, 2026
1 interpretation currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
The price sits well below its yearly mean, with net income and assets falling four years.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Peer Positioning
Gross margin is -11.2%, lower than 95% of its Conglomerates peers (median 25.8%)Significant